50
Registered beds
Somerset care home
Sunnymeade
A 50-bed residential care home in Chard, operated by Agincare (Somerset) Limited. The numbers, the CQC rating and the finance to buy, refinance or develop a home like it.
Written and reviewed by Matt Lenzie Founder & Principal Broker · 25 years arranging care home finance · Reviewed June 2026
Residential
Registration type
Good
CQC rating (22/09/2021)
£3m
Indicative value
Sunnymeade is a 50-bed residential care home in Chard, operated by Agincare (Somerset) Limited. It holds a CQC rating of Good, a solid CQC rating that supports mainstream lending appetite. For a buyer, operator or lender the numbers that matter are its 50 registered beds, its rating and the strength of the operator behind it. We arrange the finance to buy, refinance or develop a home of this kind.
Sunnymeade sits within a local market of 7 registered care homes and about 139 beds in Chard. That competitive set, and the rating profile across it, is part of how an acquisition here is underwritten.
Financing a home like Sunnymeade
Whether you are acquiring Sunnymeade, refinancing it onto better terms, or funding works, the facility is structured on the operator covenant, the CQC rating, occupancy and the fee mix. A commercial mortgage typically funds 70 to 75 percent of value over 15 to 25 years; going-concern operator finance is sized on EBITDARM; bridging covers a fast purchase or a pre-CQC period. We place the case with the lenders that back residential homes of this profile.
On an indicative basis a 50-bed home values at around £3m using an England average of about £61k per bed (LaingBuisson, a Fair Cost of Care valuation basis, not a transaction price). A trading care home is actually valued on its stabilised profit and going-concern value by a specialist healthcare valuer, so the real figure turns on occupancy, fee mix and the operator. As a rough guide a lender might advance up to about £2.1m against a home of this size and rating, sized on trading profit rather than bricks.
This home at a glance
| Registered beds | 50 |
| Type | Residential |
| CQC rating | Good |
| Operator | Agincare (Somerset) Limited |
| Indicative value | £3m |
| Indicative debt (70%) | £2.1m |
Indicative figures on a per-bed basis, not a valuation or an offer of finance.
Registered specialisms
- Caring for adults under 65 yrs
- Dementia
- Caring for adults over 65 yrs
What determines the value of Sunnymeade
A trading care home like Sunnymeade is valued as a going concern, on its stabilised trading profit (EBITDARM) capitalised at a market multiple, rather than as bricks and mortar. A specialist healthcare valuer prepares the figure, and it can sit well above or below a simple per-bed estimate depending on how the home trades. The per-bed guide above is a starting point, not a valuation.
- Occupancy: how full the home runs, and how quickly empty beds refill
- Fee mix: the balance of private, self-funded and local-authority residents
- CQC rating: Good here, a direct input to both value and lender appetite
- Staffing: care-hours per resident and agency reliance
- The building: room sizes, the en-suite and single-room share, and any capital works needed
- Location and catchment: local demand, competition and the self-funder base around Chard
Looking at other homes in the area? See care homes in Chard and the wider Somerset care market or Agincare (Somerset) Limited's full portfolio.
Other care homes in Chard
- Oak Lodge 47 beds, Good
- Sunnyside Care Home 14 beds, Good
- Chard Manor 10 beds, Good
- Springside 8 beds, Requires improvement
- Yew Tree Cottage Residential Home 7 beds, Good
More homes operated by Agincare (Somerset) Limited
- Critchill Court Frome
- Rodley House Lydney
- Paternoster House Cirencester
- The Coombs Lydney
- Henlow Court Stroud
FAQ
Financing Sunnymeade: common questions
How is Sunnymeade valued?
On its stabilised trading profit and going-concern value, assessed by a specialist healthcare valuer, not on a per-bed rule of thumb. Occupancy, the fee mix, the CQC rating (currently Good) and staffing cost all feed the figure. Send us the trading accounts and we will give a view on value and what a lender would advance.
What should I check before buying Sunnymeade?
The things that move value and fundability: the CQC rating and inspection history, occupancy and how fast beds refill, the fee mix, agency-staffing reliance, the building condition and en-suite provision, and the trading accounts behind the price. We pressure-test these as part of arranging the finance.
How much would it cost to buy a home like Sunnymeade?
On an indicative £61k-per-bed basis a 50-bed home is in the region of £3m, but a trading care home is valued on its stabilised profit and going-concern value, not a per-bed rule of thumb. The real price turns on occupancy, the fee mix and the operator. We can give a fundability view once we see the trading figures.
Can I get finance to buy Sunnymeade?
Most lenders fund up to 70 to 75 percent of value on a trading residential care home, sized on stabilised trading profit (EBITDARM). Leverage reflects the operator covenant, the CQC rating (currently Good), occupancy and the fee mix. We shortlist the lenders most likely to back a home of this profile.
Who operates Sunnymeade?
Sunnymeade is operated by Agincare (Somerset) Limited. You can see the operator's wider portfolio, bed stock and rating profile on our operator page. The operator's covenant is central to how any acquisition or refinance of this home is underwritten.
Source: Care Quality Commission care directory, 03 June 2026. Contains public sector information licensed under the Open Government Licence v3.0. Registration and bed data only; this page is care home finance information and is not affiliated with, or endorsed by, Sunnymeade or Agincare (Somerset) Limited. View the official CQC profile: cqc.org.uk.
Buying, refinancing or developing Sunnymeade?
Send us the home and the operator and we will come back with a view on fundability and likely terms within one working day.